| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
1 company
Rizzo Matthew is a Director, 10% Owner at Xtant Medical Holdings, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $123K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2018 | XTNT Xtant Medical Holdings, Inc. | Director, 10% Owner | Buy | 945,819 | $7.20 | $6,809,896.80 | +11.4% |